Investigation of Plasmodium falciparum Resistance Biomarkers among Primary School Children in Western Kenya
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in American Journal of Molecular Biology
- Vol. 12 (02), 43-53
- https://doi.org/10.4236/ajmb.2022.122005
Abstract
Background: A marked decrease in malaria-related deaths worldwide has been attributed to the administration of effective antimalarials against Plasmodium falciparum. However, the continuous spread of P. falciparum resistance to anti-malarial drugs is raising a serious problem in controlling Malaria to the vulnerable children’s immune system. In recent studies, Plasmodium falciparum Kelch 13 propeller gene (Pfk13) has been reported to develop resistance to artemisinin in South Asia. In this study, we checked Plasmodium falciparum chloroquine resistance transporter gene (Pfcrt) involved in chloroquine (CQ) resistance. Method: In this study, archived 280 samples were collected from Alupe primary school children in Busia, Western Kenya from May, 2016 to November, 2016. Genomic DNA was extracted using the MightyPrep reagent. The samples were investigated for P. falciparum positivity out of which 67 of them tested positive giving a prevalence rate of 24%. The sixty-seven were subjected to PCR amplification for the molecular marker resistance to Pfcrt. After PCR amplification, the amplicons were purified and sequenced using Sanger Sequencing. The sequence data were analyzed using BioEdit software to identify point mutations. Results: 14 samples sequences were analyzed on Bioedit software giving the following amino acid changes F76C, Y66H, L70A, Y58C, T59V, V65I, P67L, T81L, Y60S, Y66S, P67T and I71F). New mutations have been reported at position 76 leading to an amino acid change, one of Pfcrt gold standard biomarkers. However, amino acid changes Y66H, L70A, Y58C, T59V, V65I, P67L, T81L, Y60S, Y66S, P67T and I71F are newly reported giving an increase in Pfcrt prevalence of concern from zero to 5.0%. A phylogenetic evolutionary relationship was constructed as shown below. Generally, the results showed a continuous resistance of P.falciparum to Pfcrt which calls for robust continuous monitoring and surveillance. Conclusion: Due to the increase of the resistant Pfcrt gene prevalence, continuous development of new mutants against chloroquine indicates that there is need to repurpose anti-malarial drugs for future partner drugs.Keywords
This publication has 19 references indexed in Scilit:
- Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquineNature Communications, 2018
- Surveillance of Antimalarial Resistance Molecular Markers in Imported Plasmodium falciparum Malaria Cases in Anhui, China, 2012–2016The American Journal of Tropical Medicine and Hygiene, 2018
- Prevalence and distribution of malaria, Pfcrt and Pfmdr 1 genes in patients attending FUT Health Centre, Akure, NigeriaBeni-Suef University Journal of Basic and Applied Sciences, 2018
- In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine SensitivityAntimicrobial Agents and Chemotherapy, 2015
- Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, KenyaMalaria Journal, 2015
- Antimalarial Drug Resistance: In the Past, Current Status and Future PerspectivesBritish Journal of Pharmacology and Toxicology, 2015
- Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western KenyaMalaria Journal, 2015
- Molecular screening for Plasmodium falciparum resistance markers for artemisinins in Mbita, KenyaAfrican Journal of Clinical and Experimental Microbiology, 2011
- Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western KenyaInfection, Genetics and Evolution, 2009
- On the molecular mechanism of chloroquine's antimalarial action.Proceedings of the National Academy of Sciences of the United States of America, 1996